Bayer admits to $1.5 billion fund to cover expenses for Yasmin, Yaz lawsuits

by Heygood Orr and Pearson

An annual report published recently by Bayer AG has revealed that the company has set aside more than $1.5 billion to cover expenses relating to lawsuits filed by women who were injured after using Yaz or Yasmin birth control pills. These Yasmin and Yaz lawsuits have alleged that Bayer failed to properly warn patients about the increased risk of side effects they may face by using the birth control pills.

Bayer has already paid more than $1 billion to settle 4,800 Yaz and Yasmin lawsuit filed on behalf of women who suffered blood clots or other serious injuries. The company still faces more than 11,000 lawsuits involving women who took Yaz or Yasmin, including 13 class action lawsuits that have been filed in Canada.

Lawsuits filed against Bayer have alleged that women who use Yaz or Yasmin are significantly more likely to suffer blood clots than users of other birth control pills. This increased blood clots risk could put women in danger of other serious side effects, including deep vein thrombosis, heart attack, stroke, or death. Studies about the increased risk of blood clots faced by users of Yaz and Yasmin prompted the Food and Drug Administration to issue a warning in April 2012 about the danger of using these birth control pills.

In addition to the thousands of lawsuits filed by women who used Yaz or Yasmin, Bayer is also facing legal action from the federal government over its marketing of the birth control pills. According to a lawsuit filed by the U.S. Attorney General for the Eastern District of New York, Bayer allegedly promoted Yaz and Yasmin for off-label uses that it was not approved to treat by the FDA.